FCRL5

FCRL5

FCRL5 Overview

Molecule Name
Fc receptor-like protein 5
Synonyms
BXMAS1, CD307, CD307e, FCRH5, IRTA2, PRO820
Drug Development Progress
Drugs in Clinical Trials3
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
Fc Receptor-Like 5,CD307e Antigen,PRO820,CD307e,Fc Receptor Like 5,FcR-like protein 5,BXMAS1,Fc receptor homolog 5,FcRH5,Immune receptor translocation-associated protein 2,CD_antigen: CD307e,IRTA2,Immunoglobulin Superfamily Receptor Translocation Associated 2 (IRTA2)
Background
May be involved in B-cell development and differentiation in peripheral lymphoid organs and may be useful markers of B-cell stages. May have an immunoregulatory role in marginal zone B-cells.

FCRL5 Product List

Species
  • Human(6)
  • Cynomolgus(2)
  • Mouse(1)
Tag
  • His Tag(6)
  • His Tag & Avi Tag(2)
  • Fc Tag(1)
Host
  • HEK293(9)
Conjugate
  • Unconjugated(7)
  • Biotin-labeled(2)
Grade
  • RUO(9)
Low Endotoxin
  • Yes(3)
  • No(6)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
FCRL5
Cynomolgus FCRL5 Protein, His Tag, low Endotoxin (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
FCRL5
Human FCRL5 Protein, His Tag, low Endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPR

$470.00

100ug
FCRL5
HOTAvitag
FC5-H82E3
Biotinylated Human FCRL5 Protein, His,Avitag™ (MALS & SPR verified)
Human
HEK293
MALSSDS-PAGE
ELISASPR

$470.00

25ug
FCRL5
Cynomolgus FCRL5 Protein, His Tag (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE

$360.00

100ug
FCRL5
Human FCRL5 Protein, Fc Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE

$470.00

100ug
FCRL5
Human FCRL5 Protein, His Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE

$470.00

100ug
FCRL5
Human FCRL5 Protein, His Tag
Human
HEK293

$470.00

100ug
FCRL5
Avitag
FC5-H82Q3
Biotinylated Human FCRL5 Protein, Avitag™,His Tag (HPLC verified)
Human
HEK293
HPLCSDS-PAGE

$470.00

25ug
FCRL5
Mouse FCRL5 Protein, His Tag, low Endotoxin (MALS verified)
Mouse
HEK293
MALSSDS-PAGE

$360.00

100ug
You Have Viewed 1-9 Of 9 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
anti-BCMA/FcRL5 CAR T cell therapy (Xuzhou Medical University)Phase 2 ClinicalXuzhou Medical University (Xzmu)
Multiple Myeloma
Details
Anti-FcRL5 CAR-T Cell Therapy(Xuzhou Medical University)Phase 2 ClinicalXuzhou Medical University (Xzmu)
Multiple Myeloma
Details
CevostamabRG-6160; BFCR-4350A; RO-7187797Phase 2 ClinicalGenentech Inc
Lupus Erythematosus, Systemic; Multiple Myeloma
Details
Customer Reviews